Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sasaki T, Isayama H, Nakai Y, et al. A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancer. Chemotherapy. 2013;59(2):106–11.

    Article  CAS  Google Scholar 

  2. Chang TY, Chang CC, Cheng D. Acyl-coenzyme A: cholesterol acyltransferase. Ann Rev Biochem. 1997;66:613–38.

    Article  CAS  Google Scholar 

  3. Li J, Qu X, Tian J, Zhang JT, Cheng JX. Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation. PloS One. 2018;13(2):e0193318.

    Article  Google Scholar 

  4. Ueno G, Iwagami Y, Kobayashi S. ACAT-1-regulated cholesteryl ester accumulation modulates gemcitabine resistance in biliary tract cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11152-1.

Download references

Funding

No sources of funding were used to assist in the preparation of this work.

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan

    Goro Ueno MD, Yoshifumi Iwagami MD, PhD, Shogo Kobayashi MD, PhD, Suguru Mitsufuji MD, Daisaku Yamada MD, PhD, Yoshito Tomimaru MD, PhD, Hirofumi Akita MD, PhD, Tadafumi Asaoka MD, PhD, Takehiro Noda MD, PhD, Kunihito Gotoh MD, PhD, Masaki Mori MD, PhD, Yuichiro Doki MD, PhD & Hidetoshi Eguchi MD, PhD

  2. Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan

    Masaki Mori MD, PhD

Authors
  1. Goro Ueno MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshifumi Iwagami MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shogo Kobayashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suguru Mitsufuji MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daisaku Yamada MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshito Tomimaru MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hirofumi Akita MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tadafumi Asaoka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takehiro Noda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kunihito Gotoh MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masaki Mori MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yuichiro Doki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Hidetoshi Eguchi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shogo Kobayashi MD, PhD.

Ethics declarations

Disclosure

Goro Ueno, Yoshifumi Iwagami, Shogo Kobayashi, Suguru Mitsufuji, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Kunihito Gotoh, Masaki Mori, Yuichiro Doki, and Hidetoshi Eguchi have no conflicts of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ueno, G., Iwagami, Y., Kobayashi, S. et al. ASO Author Reflections: ACAT-1-Regulated Cholesteryl Ester Accumulation Modulates Gemcitabine Resistance in Biliary Tract Cancer. Ann Surg Oncol 29, 2910–2911 (2022). https://doi.org/10.1245/s10434-021-11162-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11162-z

Search

Navigation